Open Label Multi-Site Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSD
Clinical trial NCT03282123 · COMPLETED
Trial details
- NCT number
- NCT03282123
- Sponsor
- Resilient Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-16
- Primary completion
- 2019-08-10
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.